Conduit Pharmaceuticals issues $2.65M secured note at 12%, 12.5M shares to Nirland

CDT Equity Inc.

Senior Secured Promissory Note of $2,650,000 (incl. $500,000 OID), 12% interest, matures Aug 5, 2025.
$1,675,000 funded at close; $475,000 due after resale registration declared effective.
Issued 12,500,000 shares of common stock as Closing Common Stock.
Note secured by all assets; personally guaranteed by board member Dr. Andrew Regan.
Nirland gets right of first refusal to participate in future equity or debt offerings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.